Neupulse is nominated in 4 categories at the Medilink Midlands awards
The categories nominated include Innovation, One to watch, Partnership between Academia and business and Outstanding Achievement.
The categories nominated include Innovation, One to watch, Partnership between Academia and business and Outstanding Achievement.
Neupulse has secured funding to advance the world’s first wearable device aimed at tackling Tourettes Syndrome (TS) and other tic disorders towards commercialisation.
The University of Nottingham's Knowledge Exchange and Impact Awards recently honoured Professor Stephen Jackson's team at the University of Nottingham and Neurotherapeutics Ltd with the Science Faculty's award for Professor Stephen Jackson's groundbreaking research leading...
Neupulse has been awarded the prestigious Science, Technology, Engineering and Maths Research Project of the Year at the Times Higher Education Awards 2023!
Neupulse is excited to share the success of TICfest, a heartwarming event organised by Tourettes Action that brought together individuals with Tourette Syndrome and their families. It was a day of connection, learning and community.
Exciting times ahead! We're thrilled to announce that Neupulse will be participating in the upcoming TicFest on the 3rd of December, an inspiring event organised by Tourettes Action, dedicated to supporting individuals and families living...
This month, Neupulse has the honour of announcing that our Chief Scientific Officer, Professor Stephen Jackson, recognised as one of the foremost experts in the field of Tourette Syndrome, has been invited to discuss our...
We're excited to announce that Neupulse’s groundbreaking medical device has been shortlisted for the Science, Technology, Engineering and Maths (STEM) Research Project of the Year at the 2023 Times Higher Education (THE) Awards.
We are delighted to announce that Neupulse is now officially part of the TS Friendly Organisation list, an initiative by Tourette's Action (TA). This milestone was reached after our team completed the comprehensive TS Awareness...
We are thrilled to share that Neupulse had the opportunity to be a part of Aidy Smith's radio documentary, "Tourette's: The Truth Behind the Tics"
During his talk, Professor Jackson gave the background into using the peripheral nervous system to stimulate the brain to reduce the urge to tic and tic frequency
Watch a clip taken from Channel 5's Documentary 'Teacher with Tourette's' featuring the Neupulse device
Neupulse is delighted to welcome two new members to our team: Ciara McCready as a Research Assistant and Claire Hall as our Quality & Regulatory Manager.
We are excited to share the results of the UK-wide double-blind sham-controlled clinical trial of the Neupulse device for suppressing tics in Tourette syndrome.
Neupulse is excited to announce that it has recruited 2 new key executives to their senior management team.
What an incredible morning! Our team at Neupulse was honored to host Lewis Capaldi, who came to visit us in Nottingham to try out our wearable device for treating Tourette Syndrome.
Neupulse has completed a second round of funding in December 2022 of £918k. Funds have been raised from existing investors and groups of HNW individuals from around the world
Natalie Davidson (@tourettesteach), who is filming Part 2 of the documentary ‘The Teacher with Tourette’s’ with @channel5_tv, came to Nottingham to try the wearable wrist device developed by Neupulse and used in a clinical trial...
The clinical trial investigating the effects of median nerve stimulation on Tourette syndrome and associated symptoms has completed recruitment and all participants are now in the ‘follow-up period’, in which participants health is monitored for...
Will Tourette's ever be curable? Brain-altering gadget that stops involuntary tics could prove life-changing, doctors hope as Lewis Capaldi reveals he has the 'uncomfortable' syndrome
Following the program “Britain’s Tourette’s Mystery” that was aired on C4 last week which contained many inaccurate and misleading facts, Tourette’s Action UK has issues the following press release
The presentation gave the background into using the peripheral nervous system to stimulate the brain to reduce the urge to tic and tic frequency.
BBC Presenter, Aidy Smith tried Median Nerve Stimulation and was amazed at the positive impact it had on his urge to tic and gave him a very relaxed feeling with no tics.
A wearable wrist device that delivers electrical pulses to reduce the amount and severity of tics experienced by individuals with Tourette Syndrome (TS) is being tested in a UK-wide clinical trial.
Recent publications from the Neurotherapeutics team
Professor Stephen Jackson has been invited to deliver 2 Keynote addresses in the coming months describing the Neurotherapeutics Ltd approach to suppressing tics in Tourette syndrome
Neurotherapeutics are pleased to announce the start of the randomised double-blind, placebo-controlled, trial of rhythmic 10Hz median nerve stimulation for the suppression of the urge-to-tic and reduction of tics in individuals with Tourette syndrome and...
We are happy to report that an application to establish the NeuroMod+ research network was successfully funded by the EPSRC
Neurotherapeutics Ltd have now produced 80 prototype wearable medical devices for use in a UK-wide randomised double-blind placebo-controlled trial investigating the efficacy of rhythmic median nerve stimulation in suppressing the urge-to-tic in Tourette syndrome.
Neurotherapeutics won the ‘One to watch’ award with Professor Stephen and Georgina Jackson accepting the award.
Professor Stephen Jackson was Recently appointed Chair of the Scientific Advisory Board for the Federation of European Societies for Neuropsychology (FESN).
Neurotherapeutics Ltd received MHRA approval to use prototype clinical investigation devices in a new clinical study which will start in March 2022.
Neurotherapeutics Ltd has been shortlisted in 3 categories for these prestigious awards which recognises and promotes the excellence that East and West Midlands companies are achieving at the leading edge of the Life Sciences sector.
Company number: 13198315
Registered Office:
The Ingenuity Centre
University Of Nottingham Innovation Park
Triumph Road
Nottingham
England
NG7 2TU
Neupulse and Neutrack are registered trade marks of Neurotherapeutics Ltd